Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Revolution Medicines Inc (RVMD)

Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
A concept image showing a virus attacking blood cells by crystal light via Shutterstock
This Oncology Stock Just Hit New All-Time Highs Barchart - Thu Dec 4, 10:00AM CST

Revolution Medicines (RVMD) is trading at fresh all-time highs. RVMD exhibits strong technical momentum with a 100% technical “Buy” opinion from Barchart. Shares are up nearly 60% over the past year....

RVMD : 79.64 (+1.48%)
Revolution Medicines Reports Third Quarter 2025 Financial Results and Update on Corporate Progress GlobeNewswire - Wed Nov 5, 3:02PM CST

Company is winding down global enrollment for the RASolute 302 clinical trial studying daraxonrasib in patients with previously treated PDAC and remains on track for data readout in 2026 Company has initiated...

RVMD : 79.64 (+1.48%)
Revolution Medicines to Participate in November 2025 Investor Conferences GlobeNewswire - Tue Nov 4, 3:05PM CST

REDWOOD CITY, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...

RVMD : 79.64 (+1.48%)
Revolution Medicines to Report Financial Results for Third Quarter 2025 After Market Close on November 5, 2025 GlobeNewswire - Wed Oct 29, 3:05PM CDT

REDWOOD CITY, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...

RVMD : 79.64 (+1.48%)
Revolution Medicines’ RAS(ON) Multi-Selective Inhibitor Daraxonrasib Granted U.S. FDA Orphan Drug Designation in Pancreatic Cancer GlobeNewswire - Mon Oct 27, 7:00AM CDT

REDWOOD CITY, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...

RVMD : 79.64 (+1.48%)
Revolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C Inhibitor GlobeNewswire - Wed Oct 22, 11:12AM CDT

REDWOOD CITY, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...

RVMD : 79.64 (+1.48%)
Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner's National Priority Voucher Pilot Program GlobeNewswire - Thu Oct 16, 7:00PM CDT

REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...

RVMD : 79.64 (+1.48%)
Revolution Medicines Announces Key Leadership Additions, including Alan Sandler, M.D. as Chief Development Officer GlobeNewswire - Mon Sep 29, 8:00AM CDT

REDWOOD CITY, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...

RVMD : 79.64 (+1.48%)
Wall street sign in New York City by f11photo via Shutterstock
Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts Barchart - Thu Sep 11, 3:33PM CDT

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini...

AMAT : 268.00 (-0.53%)
CELH : 42.06 (-1.41%)
RCAT : 8.02 (-3.61%)
DHI : 158.62 (-1.31%)
RNA : 71.63 (+0.13%)
OXM : 40.81 (+2.59%)
BLDR : 110.01 (-0.90%)
$IUXX : 25,692.05 (+0.43%)
ASML : 1,099.47 (-0.96%)
ZNH26 : 112-165s (-0.18%)
ESZ25 : 6,878.25s (+0.17%)
PHM : 126.99 (-0.70%)
Bull on Wall Street by Alexander Naumann via Pixabay
Stocks Rally and Bond Yields Fall on Fed Rate Cut Hopes Barchart - Thu Sep 11, 10:10AM CDT

The S&P 500 Index ($SPX ) (SPY ) today is up +0.66%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.47%. September E-mini S&P futures (ESU25...

AMAT : 268.00 (-0.53%)
CELH : 42.06 (-1.41%)
RCAT : 8.02 (-3.61%)
DHI : 158.62 (-1.31%)
RNA : 71.63 (+0.13%)
OXM : 40.81 (+2.59%)
BLDR : 110.01 (-0.90%)
$IUXX : 25,692.05 (+0.43%)
ASML : 1,099.47 (-0.96%)
ZNH26 : 112-165s (-0.18%)
OXY : 42.43 (-0.56%)
ESZ25 : 6,878.25s (+0.17%)

Barchart Exclusives

Most “Safe” Dividend Stocks Don’t Grow Like This… But These 3 Did Barchart - Fri Dec 5, 6:00PM CST
Three Dividend Kings Wall Street rates “Strong Buy”, supported by strong five-year earnings growth. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot